Switch to:

Biomarin Pharmaceutical EV-to-Revenue

: 8.98 (As of Today)
View and export this data going back to 1999. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Biomarin Pharmaceutical's enterprise value is $14,401 Mil. Biomarin Pharmaceutical's Revenue for the trailing twelve months (TTM) ended in Sep. 2019 was $1,603 Mil. Therefore, Biomarin Pharmaceutical's EV-to-Revenue for today is 8.98.

NAS:BMRN' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.3   Max: 27.8
Current: 8.98

3.3
27.8

During the past 13 years, the highest EV-to-Revenue of Biomarin Pharmaceutical was 27.80. The lowest was 3.30. And the median was 11.50.

NAS:BMRN's EV-to-Revenue is ranked higher than
56% of the 802 Companies
in the Biotechnology industry.

( Industry Median: 11.82 vs. NAS:BMRN: 8.98 )

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2019-12-11), Biomarin Pharmaceutical's stock price is $79.43. Biomarin Pharmaceutical's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2019 was $8.87. Therefore, Biomarin Pharmaceutical's PS Ratio for today is 8.95.


Biomarin Pharmaceutical EV-to-Revenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Biomarin Pharmaceutical Annual Data
Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.33 19.04 12.03 11.73 9.97

Biomarin Pharmaceutical Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.29 9.97 10.37 10.10 7.64

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Biomarin Pharmaceutical EV-to-Revenue Distribution

* The bar in red indicates where Biomarin Pharmaceutical's EV-to-Revenue falls into.



Biomarin Pharmaceutical EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Biomarin Pharmaceutical's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=14400.686/1602.819
=8.98

Biomarin Pharmaceutical's current Enterprise Value is $14,401 Mil.
Biomarin Pharmaceutical's Revenue for the trailing twelve months (TTM) ended in Sep. 2019 was 353.214 (Dec. 2018 ) + 400.745 (Mar. 2019 ) + 387.763 (Jun. 2019 ) + 461.097 (Sep. 2019 ) = $1,603 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Biomarin Pharmaceutical  (NAS:BMRN) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Biomarin Pharmaceutical's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=79.43/8.87
=8.95

Biomarin Pharmaceutical's share price for today is $79.43.
Biomarin Pharmaceutical's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2019 was 1.976 (Dec. 2018 ) + 2.248 (Mar. 2019 ) + 2.166 (Jun. 2019 ) + 2.48 (Sep. 2019 ) = $8.87.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Biomarin Pharmaceutical EV-to-Revenue Related Terms


Biomarin Pharmaceutical EV-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
/* */